As part of the COVID-19 response efforts, HRSA’s Health Center Program is working in collaboration with Operation Warp Speed (OWS) and State Primary Care Associations (PCAs) to identify health centers to pilot the administration of outpatient monoclonal antibody (mAb) therapeutics to high-risk COVID-19 positive patients in outpatient settings. As of January 4, OWS has reported that 36 health centers have been allocated Bamlanivimab under the SPEED mAb Program in the following 21 states: Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Montana, North Carolina, New Hampshire, New York, Ohio, Pennsylvania, Texas, Wisconsin, and West Virginia.
Recent Posts
- Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines
- Help Pass HB 2708 to Cap Costs for West Virginians with Diabetes
- Single-Dose COVID-19 Vaccine EUA
- Dental Faculty Loan Repayment Program
- Implications of Coronavirus for People Living with HIV/AIDS
Join Us
Student, health professional, or citizen advocate?
Become a member of the West Virginia Rural Health Association.
Memberships start at $10.